Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Health Technology Assessment (Winchester, England)|May 18, 2019
Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCTMarc Serfaty, Michael King, Irwin Nazareth, et al.BMJ Open|July 25, 2025
The VIP trial: a randomised controlled trial of the clinical effectiveness of a Victim Improvement Package (VIP) for the reduction of continued symptoms of depression or anxiety in older victims of community crime in an English cityMarc Serfaty, Jessica Satchell, Teresa Lee, et al.Psycho-Oncology|December 5, 2018
Acceptance and commitment therapy for adults with advanced cancer (CanACT): A feasibility randomised controlled trialMarc Serfaty, Megan Armstrong, Victoria Vickerstaff, et al.Trials|February 12, 2016
Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trialJoseph Low, Marc Serfaty, Sarah Davis, et al.Public Health Research (Southampton, England)|April 20, 2026
The Clinical and Cost-Effectiveness of a Victim Improvement Package (VIP) for the Reduction of Chronic Symptoms of Depression or Anxiety in Older Victims of Community-Crime: the VIP RCT SynopsisMarc Serfaty, Jessica Satchell, Anthony Kessel, et al.Health Technology Assessment (Winchester, England)|November 11, 2025
Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson's disease: the ADepT-PD RCT pilotAnette Schrag, Camille Carroll, Glyn Lewis, et al.Trials|April 18, 2020
The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trialMarc Serfaty, Trefor Aspden, Jessica Satchell, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 13, 2019
Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty R Weeks, Rebecca L Gould, Christopher Mcdermott, et al.Pageof 4